OPTISCHES DOSISDEKODIERVERFAHREN

Patent europeic · EP3248637 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3248637
Numer da la dumonda
EP17170336
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
13-01-2014
Publitgà
29-11-2017
Concedì
04-11-2020
La protecziun finescha il pli tard
12-01-2034
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
A61M 5/315 (2006.01)
H04L 9/32 (2006.01)
A61M 5/20 (2006.01)
A61M 5/24 (2006.01)
G01D 5/12 (2006.01)
G01D 5/26 (2006.01)
G01D 5/347 (2006.01)
Prioritad
EP 13151368 15.01.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-02-2026

    Midada

    Published in Swissreg on 01.02.2026

  2. 01-02-2025

    Midada

    Published in Swissreg on 01.02.2025

  3. 01-02-2024

    Midada

    Published in Swissreg on 01.02.2024

  4. 01-02-2023

    Midada

    Published in Swissreg on 01.02.2023

  5. 04-11-2020

    Concedì

    Published in Swissreg on 04.11.2020

Partidas

Possessur

Sanofi-Aventis Deutschland GmbH

Brüningstraße 50, 65929 Frankfurt, DE

Inventur

MORRIS, Anthony Paul

Coventry, West Midlands CV7 7FY, GB

GILMORE, Stephen Francis

Bristol, BS1 6XD, GB

DRAPER, Paul Richard

Evesham, Worcestershire WR11 3FE, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.